Intrinsiqq

LNA Santé SA (LNA.XPAR) Quality Score

LNA.XPAR
Quality47

Business quality is the primary weakness (avg 25/100). Valuation is the relative bright spot.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
100/100
9.9x

Under 20x, reasonable relative to earnings

Cash Flow Multiple
100/100
2.8x

Under 20x cash flow, well covered

Revenue Growth
70/100
7.8%

5–10% CAGR, steady but not exceptional

Cash Flow Growth
0/100
-1.3%

Below 2%, essentially flat

Business Quality & Capital Allocation

Share Dilution
80/100
-1.0%

Roughly flat, no meaningful dilution

Margin Trend
20/100
-0.6pp

Modest contraction, within normal range

Capital Structure
0/100
€812M

Net debt/FCF of 9.4x, high leverage

2022
€102M
€912M
2023
€78M
€887M
2024
€75M
€875M
2025
€95M
€906M
Return on Capital
0/100
4.0%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

LNA Santé SA (LNA.XPAR) quality: score, margins and returns

LNA Santé SA (LNA.XPAR) scores 47/100 on Intrinsiqq's quality score (a mixed business), a weighted blend of 8 metrics each scored 0 to 100, on 8.2% operating margins and 4.0% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is LNA Santé SA (LNA.XPAR) a high-quality business?+

LNA Santé SA scores 47 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a mixed business on these measures. Recent figures include a 8.2% operating margin and a 4.0% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does LNA Santé SA's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from LNA.XPAR's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where LNA Santé SA scores well and where it falls behind.

What is LNA Santé SA's return on invested capital (ROIC)?+

LNA Santé SA earns about 4.0% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to LNA.XPAR's margins and growth on this scorecard to judge durability.

How profitable is LNA Santé SA?+

LNA Santé SA runs an operating margin of about 8.2% and a net margin of about 2.8%. Revenue has grown at roughly 7.3% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Related stocks: Medical Care Facilities

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.